Correlation Between Affimed NV and ImmunoGen
Can any of the company-specific risk be diversified away by investing in both Affimed NV and ImmunoGen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Affimed NV and ImmunoGen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Affimed NV and ImmunoGen, you can compare the effects of market volatilities on Affimed NV and ImmunoGen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Affimed NV with a short position of ImmunoGen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Affimed NV and ImmunoGen.
Diversification Opportunities for Affimed NV and ImmunoGen
-0.7 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Affimed and ImmunoGen is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Affimed NV and ImmunoGen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ImmunoGen and Affimed NV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Affimed NV are associated (or correlated) with ImmunoGen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ImmunoGen has no effect on the direction of Affimed NV i.e., Affimed NV and ImmunoGen go up and down completely randomly.
Pair Corralation between Affimed NV and ImmunoGen
Given the investment horizon of 90 days Affimed NV is expected to under-perform the ImmunoGen. But the stock apears to be less risky and, when comparing its historical volatility, Affimed NV is 1.92 times less risky than ImmunoGen. The stock trades about -0.04 of its potential returns per unit of risk. The ImmunoGen is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 547.00 in ImmunoGen on August 23, 2024 and sell it today you would earn a total of 1,273 from holding ImmunoGen or generate 232.72% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 32.26% |
| Values | Daily Returns |
Affimed NV vs. ImmunoGen
Performance |
| Timeline |
| Affimed NV |
| ImmunoGen |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Affimed NV and ImmunoGen Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Affimed NV and ImmunoGen
The main advantage of trading using opposite Affimed NV and ImmunoGen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Affimed NV position performs unexpectedly, ImmunoGen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ImmunoGen will offset losses from the drop in ImmunoGen's long position.| Affimed NV vs. Pieris Pharmaceuticals | Affimed NV vs. ADC Therapeutics SA | Affimed NV vs. Agenus Inc | Affimed NV vs. X4 Pharmaceuticals |
| ImmunoGen vs. Madrigal Pharmaceuticals | ImmunoGen vs. TG Therapeutics | ImmunoGen vs. Terns Pharmaceuticals | ImmunoGen vs. Hepion Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |